Type 2 diabetes and Change in Total Hip Bone Area and Bone Mineral Density in Elderly Swedish Men and Women: Supplementary material

SND-ID: 2024-327. Version: 1. DOI: https://doi.org/10.57804/ryn2-9s58

Citation

Creator/Principal investigator(s)

Adam Mitchell - Uppsala University, Department of Surgical Sciences, Medical epidemiology

Tove Fall - Uppsala University, Department of Medical Sciences, Molecular epidemiology orcid

Håkan Melhus - Uppsala University, Department of Medical Sciences, Clinical pharmacogenomics and osteoporosis orcid

Lars Lind - Uppsala University, Department of Medical Sciences orcid

Karl Michaëlsson - Uppsala University, Department of Surgical Sciences, Medical epidemiology orcid

... Show more..

Adam Mitchell - Uppsala University, Department of Surgical Sciences, Medical epidemiology

Tove Fall - Uppsala University, Department of Medical Sciences, Molecular epidemiology orcid

Håkan Melhus - Uppsala University, Department of Medical Sciences, Clinical pharmacogenomics and osteoporosis orcid

Lars Lind - Uppsala University, Department of Medical Sciences orcid

Karl Michaëlsson - Uppsala University, Department of Surgical Sciences, Medical epidemiology orcid

Liisa Byberg - Uppsala University, Department of Surgical Sciences, Medical epidemiology orcid

Show less..

Research principal

Uppsala University rorId

Description

Supporting data to the manuscript "Type 2 diabetes and Change in Total Hip Bone Area and Bone Mineral Density in Elderly Swedish Men and Women"

In SMCC, Fasting plasma glucose concentrations were analysed using three different methods depending on date of collection; glucose dehydrogenase reagent (Bergman & Beving, instrument Advia 1650, Stockholm, Sweden), glucose oxidase method (Bayer, instrument Advia 1650, Leverkusen, Germany), and hexokinase method (Abbott, Abbott Architect, Illinois, USA).

In PIVUS, fasting plasma glucose concentrations were analysed using the standard method at Uppsala University Hospital.

In ULSAM, fasting plasma glucose concentrations (mmol/l) were measured by the glucose dehydrogenase method (Gluc-DH, Merck, Darmstadt, Germany).

The dataset was originally published in DiVA and moved to SND in 2024.

Data contains personal data

No

Language

Method and outcome
Data collection
Geographic coverage
Administrative information

Funding 1

  • Funding agency: Vetenskapsrådet
  • Funding agency's reference number: 2015-03257

Funding 2

  • Funding agency: Forte, Forskningsrådet för hälsa, arbetsliv och välfärd

Funding 3

  • Funding agency: Region Uppsala

Identifiers

Topic and keywords

Research area

Orthopaedics (Standard för svensk indelning av forskningsämnen 2011)

Publications
Published: 2024-06-25